What is the most likely diagnosis and appropriate treatment for a hypopigmented, slightly scaly patch on the chest and back of an elderly female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Hypopigmented Patch on Chest and Back in Elderly Female: Diagnosis and Treatment

The most likely diagnosis is tinea versicolor (pityriasis versicolor), and treatment should consist of topical antifungal agents such as ketoconazole cream or selenium sulfide shampoo applied to affected areas.

Clinical Reasoning

A hypopigmented, slightly scaly patch on the chest and back in an elderly female most commonly represents tinea versicolor, a superficial fungal infection caused by Malassezia species. This presentation—hypopigmented macules with fine scaling on the trunk—is pathognomonic for this condition 1.

Key Diagnostic Features to Confirm:

  • Distribution: Chest, back, shoulders, and upper arms are classic sites
  • Appearance: Well-defined hypopigmented macules with fine, adherent scales
  • Scale quality: "Spaghetti and meatballs" appearance on KOH preparation (short hyphae and round spores)
  • Wood's lamp examination: May show yellow-green fluorescence
  • Dermoscopy: Nonuniform perifollicular hypopigmentation with clearly demarcated borders and patchy scaling 1

Critical Differential Diagnoses to Exclude:

While tinea versicolor is most likely, you must actively rule out:

  1. Hypopigmented mycosis fungoides (HMF): This is the most important diagnosis not to miss, as it represents cutaneous T-cell lymphoma. Consider HMF if:

    • Patches are persistent despite antifungal treatment
    • Lesions show atrophy or poikiloderma
    • Patient is younger (though can occur at any age)
    • Patches have been present for years without response to standard therapy 2, 3, 4

  2. Idiopathic guttate hypomelanosis: Typically smaller (2-5mm), porcelain-white macules on sun-exposed areas in elderly patients

  3. Post-inflammatory hypopigmentation: Requires history of preceding inflammatory dermatosis

Treatment Algorithm

First-Line Treatment:

  • Topical ketoconazole 2% cream applied once daily for 2-4 weeks, OR
  • Selenium sulfide 2.5% shampoo applied to affected areas, left on for 10 minutes, then rinsed off, repeated 2-3 times weekly for 2-4 weeks

If Extensive Disease:

  • Oral fluconazole 400mg single dose or itraconazole 200mg daily for 5-7 days

Expected Response:

  • Scaling should resolve within 1-2 weeks
  • Hypopigmentation may persist for months after fungal eradication (this is normal and does not indicate treatment failure)
  • Recurrence is common; prophylactic monthly treatment may be needed 1

Critical Pitfall to Avoid

Do not assume all hypopigmented patches are benign fungal infections. If the patient fails to respond to adequate antifungal therapy after 4-6 weeks, or if clinical features are atypical (significant atrophy, poikiloderma, persistent patches despite treatment), perform a skin biopsy immediately to exclude hypopigmented mycosis fungoides 2, 3. HMF can be misdiagnosed for years as tinea versicolor, leading to delayed treatment of a malignancy. The atrophic variant of pityriasis versicolor is extremely rare and should prompt consideration of biopsy 1.

When to Biopsy:

  • No response to 4-6 weeks of appropriate antifungal therapy
  • Atrophic changes present
  • Patches present for >1 year
  • Progressive disease despite treatment
  • Clinical suspicion for lymphoma

Histopathology in tinea versicolor shows fungal hyphae and spores in the stratum corneum with minimal inflammation 1. HMF shows epidermotropism with atypical CD8+ lymphocytes and requires immunohistochemistry for definitive diagnosis 2, 4.

References

3
Research

An illustrative case of hypopigmented mycosis fungoides.

SAGE open medical case reports, 2025

Related Questions

What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
Is a low dicrotic notch associated with vasoplegia or vasodilation?
For a patient with a confirmed cow‑milk protein allergy, which dairy product is more allergenic: yogurt, cheese, or butter?
I recently started progesterone and now have marked sleepiness, chills, and fatigue; could these symptoms be caused by the progesterone or indicate adrenal insufficiency or untreated hypothyroidism?
What is the recommended first‑line pharmacologic management for absence seizures?
What is the normal resting blood pressure range for a healthy 24-year-old male?
How should postoperative sciatica pain be managed after lumbar laminectomy and instrumented fusion in an adult patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.